Injectable Drugs For Type-2 Diabetes Market Share

North America industry is estimated to hold largest revenue share by 2037, backed by increasing prevalence of type 2 diabetes and obesity in the region.

Currently, North America region holds the maximum market share on the back of increasing prevalence of type 2 diabetes and obesity in the region along with the presence of world’s leading contributor, USA, in this field. Asian countries are expected to show significant growth owing to the initiatives taken by local government and health organizations to spread awareness about diabetes and its management using drugs and devices.